Women’s deep belly fat more strongly linked to diabetes and cardiovascular diseases
2019-09-10
A comprehensive study from IGP, with over 325,000 participants, shows that deep belly fat is a major contributing risk factor for developing diabetes and cardiovascular disease. The study also shows that deep belly fat is a larger risk factor in women compared to men. Moreover, the scientists investigated how our genes affect the accumulation of fat and present a new, simpler method to estimate the amount of deep belly fat.
Visceral fat – fat stored around the organs in the belly and around the intestines – is known to be associated with a higher risk of developing diabetes and cardiovascular disease. In the new study, published in Nature Medicine, the scientists took it one step further and showed, using genetic data, that there is an actual causal relationship between visceral fat and increased risk of diabetes, heart attack, hypertension and hyperlipidemia.
The scientists developed a method to more easily estimate visceral fat content. The method is not only useful for research purposes, but may also be useful in health care.
“To measure the amount of visceral fat, advanced and costly diagnostic imaging techniques are required. We have developed a simple method which instead estimates an individual’s amount of deep belly fat from other parameters, more easily measured than the visceral fat itself, and the method can therefore be used in most clinics,” says Torgny Karlsson, statistician at IGP and one of the leading researchers of the study.
The method also enabled the researchers to study the effects of visceral fat on a much larger scale than before.
“We were surprised that visceral fat was more strongly linked to risk of disease in women compared to men. Adding an extra kilogram of visceral fat can increases the risk of type 2 diabetes more than seven times in women, while the same amount of fat accumulation only increases the risk a little more than two times in men,” says Åsa Johansson, last author of the published paper.
The scientists also found that the risk of disease increases most rapidly in people with small or moderate amounts of deep belly fat, but that it does not increase nearly as much if a person with large amounts of fat in the abdomen puts on additional fat.
“Nonlinear effects like this are very interesting to study and may help us to understand the biology behind the link between visceral fat and disease,” says Torgny Karlsson.
The scientists also examined millions of positions in the genome to identify genes that affect the amount of visceral fat, and found more than two hundred different genes. Among these, there was a large proportion of genes that are linked to our behaviour, which suggests that the main contributor to abdominal obesity is, after all, that we eat too much and exercise too little. However, there are individual differences in how the fat is distributed in the body, and a person who appears not to be overweight may still have accumulated a harmful amount of visceral fat.
“The findings of this study may enable us to simplify measurements of visceral fat, and thus more easily identify people at high risk of developing diabetes and cardiovascular disease,” says Torgny Karlsson.
More information:
Paper in Nature Medicine
Research in Åsa Johansson’s group
-
Drug against epilepsy inhibits tumour development in the brain
2019-11-28
Medication against a certain type of epilepsy can be a new way to treat malignant brain tumours in infants. A specific mTOR inhibitor can cross the blood-brain barrier and both reach and attack the tumour where it is located. This is shown by IGP researchers, in collaboration with American and British colleagues, and the results are published in the scientific journal Cell Stem Cell.
-
New combination of drugs effective against aggressive brain tumour
2019-11-25
Researchers at IGP have identified a certain group of patients with malignant glioblastoma brain tumours that respond to a therapy targeting the cancer gene MYCN. The research findings are published in the scientific journal Cell Death & Disease.
-
Correlation found between loss of chromosome Y and genetic instability
2019-11-20
In an international collaboration, researchers from IGP have shown that loss of chromosome Y in the blood in men can function as an indicator of genetic instability, which in turn can affect the susceptibility for cancer in other parts of the body. The study has been published in the journal Nature.
-
Analysis using whole genome sequencing gives more accuracy
2019-11-20
A new study from IGP shows that whole genome sequencing contributes to increasing the accuracy in genetic studies, which in turn can improve the understanding of how biomarkers can be used to discover diseases. The results are published in the scientific journal Scientific Reports.
-
Mechanism for the formation of new blood vessels discovered
2019-09-23
In a new study published in the journal EMBO Reports, researchers from IGP show for the first time a mechanism for how new blood vessels are formed and the importance of this mechanism for embryo survival and organ function. The results could be developed to control the formation of new blood vessels in different diseases.
-
Women’s deep belly fat more strongly linked to diabetes and cardiovascular diseases
2019-09-10
A comprehensive study from IGP, with over 325,000 participants, shows that deep belly fat is a major contributing risk factor for developing diabetes and cardiovascular disease. The study also shows that deep belly fat is a larger risk factor in women compared to men. Moreover, the scientists investigated how our genes affect the accumulation of fat and present a new, simpler method to estimate the amount of deep belly fat.
-
Three new parts of the database The Human Protein Atlas
2019-09-09
The HPA project has recently released a new version of The Human Protein Atlas. This is the most extensive update so far, with the completely new parts Blood Atlas, Brain Atlas, and a Metabolic Atlas, developed in collaboration with Chalmers University.
-
New WHO reagent for autoantibodies in SLE patients
2019-09-06
A new study published in the journal Annals of the Rheumatic Diseases presents a WHO reference reagent produced by an international team of researchers and clinical laboratories. This reagent will facilitate the adjustment of autoantibody analyses in SLE and thereby also diagnosis and therapy for SLE patients.
-
Novel method identifies the right individual exosomes
2019-08-28
There is a growing demand for diagnostic markers for early disease detection and prognosis. Exosomes are potential biomarkers for cancer progression and neurodegenerative disease but it can be difficult to identify what tissue a specific exosome comes from. Researchers at IGP and spin-off company Vesicode AB have solved this problem by developing a method that maps surface protein complements on large numbers of individual exosomes.
-
Newly discovered signalling pathways important for future brain cancer therapy
2019-08-21
Each year, more than 1 300 people in Sweden are diagnosed with brain cancer. An international collaboration with researchers from the University of Wales, the United States and IGP have now uncovered molecular targets that might lead to a new generation of brain cancer therapies. The results are published today in a paper in the journal Cancer Discovery.
-
Multiple genes affect risk of asthma, hay fever and eczema
2019-08-19
In a new study from IGP, researchers have found a total of 141 regions (genes) in our genetic material that largely explain the genetic risk underlying asthma, hay fever and eczema. As many as 41 of the genes identified have not previously been linked to an elevated risk for these diseases. The results are published in the scientific journal Human Molecular Genetics.
-
New biomarker test improves diagnosis of ovarian cancer
2019-07-01
The majority of women who undergo surgery for suspected ovarian cancer do not have cancer. A novel blood test developed by Ulf Gyllensten’s research group, together with colleagues at Uppsala University and the Sahlgrenska Academy, at University of Gothenburg, now offers the possibility of more precise diagnostics without the need for surgery. This could lead to a reduction in unnecessary surgery and to earlier detection and treatment for affected women.
-
Inhibition of ribosome biogenesis as a novel approach for multi-stage cancer treatment
2019-06-05
Nearly ninety per cent of all cancer patient deaths are due to metastasis. A study from IGP shows that a process that allows the cells to metastasise is aided by the synthesis of new ribosomes, the cell components in which proteins are produced. The results open the possibility for new treatment strategies for advanced cancers. The study is published in Nature Communications.
-
Our genes affect where fat is stored in our bodies
2019-06-05
A recent study from IGP has found that whether you store your fat around the trunk or in other parts of your body is highly influenced by genetic factors and that this effect is present predominantly in women and to a much lower extent in men. In the study, which is published in Nature Communications, the researchers measured how fat was distributed in nearly 360,000 voluntary participants.
-
Cytogenetic complexity can predict disease course in chronic lymphocytic leukemia
2019-06-05
Evaluation of cytogenetic complexity could improve prognosis and predict therapy response for the cancer disease chronic lymphocytic leukemia. This is shown by IGP researcher Panagiotis Baliakas, together with an international research team, in a recently published article in the journal Blood.